Skip to content

MDMA: all studies

Page 215 of 345: studies 2,141 to 2,150 of 3,446, newest first. Back to the MDMA overview

Research

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction January 30, 2025 Theodore Piper, Francesca Small, Michael Kelleher et al. 27 citations

Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its quality; and to offer recommendations for...

Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications

Pharmaceuticals January 19, 2025 Marco Bonaso, Letizia Biso, Benedetta Zucchini et al. 13 citations

Psychedelics, historically celebrated for their cultural and spiritual significance, have emerged as potential breakthrough therapeutic agents due to their profound effects on consciousness, emotional processing, mood, and neural plasticity. This review explores the mechanisms underlying psychedelics’ effects, focusing on their ability to modulate brain connectivity and neural circuit activity,...

The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.

Journal of Affective Disorders January 15, 2025 Jia-Ru Li, Kuo-Tung Chiang, Yu-Chen Kao et al. 1 citation

Different study designs of psychedelic trials may impact the blinding and expectance, leading to biased treatment effects. This study aimed to examine the association between antidepressant efficacy and study designs in psychedelic trials. Six databases were systematically searched. Eligible trials were required to investigate the efficacy of psychedelics (psilocybin, lysergic acid diethylamide...

Comparative Mysticism

Comparative philosophy of religion 2025 Thorsten Botz-Bornstein 1 citation

AbstractMysticism is mostly employed in the context of theistic religions because historically, mysticism aims at a unification with God. It must be clarified if the project of comparative mysticism that this book suggests can be properly carried out when including non-theistic religions. The chapter examines phenomena such as quietism, ekstasis, and contemplation. Further, the relationship...

Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community

Figshare 2025 Daniel J. Kruger, Gina Mersereau, Ashley Sullivan et al. preprint

Abstract Background The use of psychedelics is currently increasing in the United States. Awareness of clinical trials investigating the therapeutic applications of psychedelics may result in a record number of people who use psychedelics for the first-time. This study aimed to develop a harm-reduction resource to facilitate safe and successful psychedelic experiences outside of regulated...

An Update on the Epidemiology of Tusi ("Pink Cocaine").

Current Addiction Reports 2025 Nina Abukahok, Nicole D. Fitzgerald, Joseph J Palamar

Tusi, also known as "pink cocaine," has emerged across nightlife scenes in Latin America, Europe, Australia, and the United States (US). Tusi is typically a drug mixture containing ketamine and 3,4-methylenedioxymethamphetamine (MDMA). Due to tusi's inconsistent chemical makeup, surveillance and harm reduction efforts have proven difficult for researchers and consumers alike. This review...

The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.

Therapeutic Advances in Psychopharmacology 2025 Diana McHerron, Michaela Barber, Rachel Ham et al.

Physical touch is often included as a supportive or therapeutic tool in psychedelic-assisted therapy (PAT), involving instrumental forms of physical contact, supportive touch and somatic techniques. However, participants under the influence of psychedelics have reduced capacity to provide consent, are more suggestible and may experience and interpret therapeutic touch in ways they did not...

PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.

Frontiers in Psychiatry 2025 Julia Marek, Magdalena Domek-Gumprecht, Agata Macionga et al.

PolDrugs is a biennial epidemiological study aimed at analyzing patterns of mostly illicit psychoactive substance use in Poland in the context of psychiatry and harm reduction. This survey was held for the third time, and its results were compared to the last two editions. The survey was conducted as an online survey with 37 closed-ended single-choice questions and 3 multiple-choice questions....

Post-traumatic stress disorder in psychedelic research.

International review of neurobiology 2025 Tijmen Bostoen, Stephan Tap, Joost J. Breeksema et al. 1 citation

Post-Traumatic Stress Disorder (PTSD) is a severe psychiatric condition that develops after exposure to trauma such as combat, natural disasters, or assault. It is characterized by re-experiencing trauma, avoidance, hyperarousal, and negative alterations in cognition and mood. Since its formal inclusion in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-III in 1980, PTSD has...

Biological treatments for co-occurring eating disorders and psychological trauma: a systematic review.

Frontiers in Psychiatry 2025 Ella van Beers, Irene de Vries, Caroline Planting et al. 2 citations

Many people with eating disorders report having experienced childhood maltreatment or a traumatic event prior to developing an eating disorder. Although many people with eating disorders have significant traumatic exposure or symptoms of post-traumatic stress disorder, very little research has examined the effects of combined treatments for this group. The purpose of this systematic review was...